Patents by Inventor Elouard Benchikh

Elouard Benchikh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mephedrone detection
    Patent number: 9128108
    Abstract: The invention relates to an immunoassay method and kit for the detection and/or the determination of mephedrone, mephedrone metabolites and related compounds. The invention is underpinned by a novel antibody, derived from a novel immunogen, that is sensitive and binds to mephedrone, mephedrone metabolites and related compounds.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: September 8, 2015
    Assignee: Randox Laboratories Limted
    Inventors: Robert Ivan McConnell, Elouard Benchikh, Philip Andrew Lowry, Stephen Peter Fitzgerald
  • Immunoassay for cyclopropylindole based synthetic cannabinoids, metabolites and derivatives thereof
    Patent number: 9079964
    Abstract: The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and their metabolites.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: July 14, 2015
    Assignee: RANDOX LABORATORIES LIMITED
    Inventors: Elouard Benchikh, Ivan McConnell, Philip Lowry, Peter Fitzgerald
  • Tilidine Immunodetection
    Publication number: 20150185241
    Abstract: An immunoassay for the detection of tilidine and nortilidine is described. The invention also describes antibodies and kits.
    Type: Application
    Filed: December 19, 2014
    Publication date: July 2, 2015
    Inventors: Elouard Benchikh, Peter Stephen Fitzgerald, Ivan McConnell, Philip Lowry
  • DETECTION OF SYNTHETIC CANNABINOIDS
    Publication number: 20150118763
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: November 7, 2014
    Publication date: April 30, 2015
    Inventors: STEPHEN PETER FITZGERALD, PAUL JOHN INNOCENZI, IVAN ROBERT McCONNELL, PHILIP ANDREW LOWRY, ELOUARD BENCHIKH
  • Immunoassay for Phenethylamines of the 2C and DO Sub-Families
    Publication number: 20150038366
    Abstract: Immunoassay methods and their requisite components for the detection and determination of phenethylamines of the 2C and DO sub-families are described.
    Type: Application
    Filed: August 5, 2014
    Publication date: February 5, 2015
    Inventors: Elouard Benchikh, Peter Fitzgerald, Ivan McConnell, Philip Lowry
  • Detection of synthetic cannabinoids
    Patent number: 8906633
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: December 9, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Immunodetection and quantification of pyrazolopyrimidine sedatives
    Patent number: 8852953
    Abstract: The invention relates to novel immunogens, antibodies, methods and kits for use in immunoassays to detect and quantify zaleplon, metabolites of zaleplon and indiplon. These are the first described immunoassays for these compounds and have greater sensitivity than alternative analytical techniques.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: October 7, 2014
    Assignee: Randox Laboratories Ltd.
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Philip Andrew Lowry, Ivan Robert McConnell
  • IMMUNOASSAY FOR CYCLOPROPYLINDOLE BASED SYNTHETIC CANNABINOIDS, METABOLITES AND DERIVATIVES THEREOF
    Publication number: 20140287441
    Abstract: The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and their metabolites.
    Type: Application
    Filed: October 30, 2013
    Publication date: September 25, 2014
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Ivan McConnell, Philip Lowry, Peter Fitzgerald
  • Immunoassay for Detecting Kratom, its Constituents and their Use
    Publication number: 20140242617
    Abstract: The invention relates to the field of drug detection and describes antibody-based components methods and kits for the detection and quantification of alkaloids of the plant kratom. The invention is underpinned by novel antibodies which specifically bind to mitragynine alkaloids found in the kratom plant and their metabolites.
    Type: Application
    Filed: February 19, 2014
    Publication date: August 28, 2014
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Ivan McConnell, Philip Lowry, Peter Fitzgerald
  • Ritalinic Acid Immunoassay
    Publication number: 20140242618
    Abstract: The invention provides novel antibodies which specifically bind to the methylphenidate metabolite, ritalinic acid, enabling an immunoassay that can detect methyphenidate in biological samples for an extended period following its ingestion. The invention also describes novel conjugates and kits incorporating the antibodies.
    Type: Application
    Filed: February 21, 2014
    Publication date: August 28, 2014
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Philip Lowry, Elouard Benchikh, Ivan McConnell, Peter Fitzgerald
  • Sensitive and generic antibodies and multiple applications
    Patent number: 8735556
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 27, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • IMMUNOASSAYS FOR MEPERIDINE AND METABOLITES
    Publication number: 20140099651
    Abstract: The invention provides novel haptens and immunogens for the preparation of novel monoclonal antibodies, which detect the synthetic opioid meperidine and its active metabolite normeperidine. These antibodies enable methods and kits, which are useful in an immunoassay for therapeutic drug monitoring (TDM) and in extending the window of detection for cases of abuse and drug-facilitated sexual assault (DFSA).
    Type: Application
    Filed: October 8, 2013
    Publication date: April 10, 2014
    Inventors: Ivan McConnell, Elouard Benchikh, Philip Lowry, Peter Fitzgerald
  • Immunoassay with extended detection window
    Patent number: 8673652
    Abstract: The immunoassay method and kit are provided for the detection and/or the determination of zolpidem. The disclosure provides novel antibodies, derived from a novel immunogen, that are highly sensitive and bind to zolpidem and its main urinary metabolite [3-(2-N,N-dimethylamino-2-oxoethyl)-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid, enabling an extension of the detection window of zolpidem in individuals who have abused the drug, or have been victim of its side-effects or its criminal misuse.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: March 18, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Stephen Peter Fitzgerald, Robert Ivan McConnell, Philip Andrew Lowry, Elouard Benchikh
  • Assay for Benzylpiperazine and Metabolites
    Publication number: 20140004623
    Abstract: The invention relates to the detection and quantification of 1-benzylpiperazine and its metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Application
    Filed: July 1, 2013
    Publication date: January 2, 2014
    Inventors: Elouard BENCHIKH, Ivan McCONNELL, Philip LOWRY, Peter FITZGERALD
  • Glutathione S-transferase omega 1 wild type specific antibody
    Patent number: 8617828
    Abstract: The invention relates to a novel antibody which binds to wild type (wt) Glutathione S-transferase Omega 1 (wtGSTO1) but not to mutant (mut) GSTO1 and methods and uses based on the antibody. The antibody is based on novel haptens and immunogens.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: December 31, 2013
    Assignee: Randox Laboratories Limited
    Inventors: Peter Stephen Fitzgerald, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh
  • MULTI-ANALYTE MICROARRAYS USING TAG-SPECIFIC ANTIBODIES AND TAG-ANCHORED ANTIBODIES
    Publication number: 20130310277
    Abstract: The invention describes accurate and flexible methods and kits for conducting multi-analyte microarrays through the use of Tag-specific antibodies and analyte-specific Tag-anchored antibodies.
    Type: Application
    Filed: December 20, 2011
    Publication date: November 21, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzgerald, Elouard Benchikh, Ivan McConnell, Philip Andrew Lowry
  • Chloral hydrate detection
    Patent number: 8530177
    Abstract: The invention relates to an immunoassay method and kit for the indirect detection of chloral hydrate. The invention is underpinned by a novel immunogen that produces an antibody that is specific for the chloral hydrate metabolite trichloroethanol glucuronide. Detection and quantification of trichloroethanol glucuronide has important applications in clinical toxicology, drug facilitated crime, water testing and solvent exposure.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: September 10, 2013
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Ivan McConnell, Peter Fitzgerald, Philip Lowry
  • Detection of Synthetic Cannabinoids
    Publication number: 20130196354
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and RCS families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: August 14, 2012
    Publication date: August 1, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzgerald, Paul John Innocenzi, Elouard Benchikh, Philip Andrew Lowry, Ivan Robert McConnell
  • MCPP immunoassay
    Patent number: 8476029
    Abstract: The invention describes a practical and robust multi-antibody approach to the sensitive immunodetection and determination of the drug of abuse m-chlorophenyl piperazine (mCPP). The invention also describes methods and kits for mCPP detection in an in vitro sample.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: July 2, 2013
    Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Paul John Innocenzi, Philip Andrew Lowry, Ivan Robert McConnell
  • Detection of Synthetic Cannabinoids
    Publication number: 20130066053
    Abstract: The invention describes methods and kits for detecting and determining current and future synthetic cannabinoids from the JWH and CP families. Unique antibodies derived from novel immunogens enable said methods and kits.
    Type: Application
    Filed: August 14, 2012
    Publication date: March 14, 2013
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Stephen Peter Fitzberald, Ivan Robert McConnell, Paul John Innocenzi, Elouard Benchikh, Philip Andrew Lowry